FDA ends Teva Plan B OTC dominance

Share this article:

Plan B is now going generic. NPR reports that the FDA did a 180 on its July 2012 marketing decision that allowed the emergency contraception to be sold over the counter without an age restriction.

The age-free availability came after legal wrangling that brought together the FDA, the Department of Justice, and the United States District Court for the Eastern District of New York.

Pro-limit parties, which included the Department of Justice and the White House, backed off, keeping it out of the Supreme Court. The détente came with a provision in which the FDA granted drugmaker Teva three years of generic protection. NPR reports that the regulator has changed its mind as long as generic labels note that the drug is meant for women 17 or older.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.